Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.59 |
| ▸ | TSHR | P16473 | 3/20 | 0.59 |
| ▸ | GAA | P10253 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.59 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | RGS12 | O14924 | 1/20 | 0.59 |
| ▸ | APEX1 | P27695 | 1/20 | 0.59 |
| ▸ | THPO | P40225 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.59 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2710180 | 1.00 | MAPT (0.59) | MAPTTSHRGAAKDM4EPOLB | |
| Nitric Acid SCHEMBL7984255 | 0.97 | MAPT (0.56) | MAPTTSHRGAAKDM4EPOLB | |
| SCHEMBL7564083 | 0.88 | POLB (0.52) | MAPTTSHRGAAKDM4EPOLB | |
| SCHEMBL6379699 | 0.86 | GAA (0.59) | MAPTTSHRGAAKDM4EPOLB | |
| SCHEMBL2434953 | 0.86 | GAA (0.59) | MAPTTSHRGAAKDM4EPOLB | |
| SCHEMBL1865824 | 0.86 | CASP6 (0.55) | MAPTTSHRGAAKDM4EPOLB | |
| SCHEMBL2742575 | 0.85 | MAPT (0.58) | MAPTTSHRKDM4EPOLBHPGD | |
| SCHEMBL13520189 | 0.85 | POLB (0.52) | MAPTTSHRKDM4EPOLBHPGD | |
| SCHEMBL7126615 | 0.85 | POLB (0.52) | MAPTTSHRKDM4EPOLBHPGD | |
| SCHEMBL3533309 | 0.83 | POLB (0.51) | MAPTTSHRKDM4EPOLBHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 496 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| WO-2025085675-A1 | CONJUGATES, COMPOSITIONS AND METHODS FOR TREATING RSV INFECTION | NIEDRAUER MARY LYNN (US) | 2025-04-24 | — | — | WO | claimed |
| WO-2025085664-A1 | CONJUGATES, COM POSITIONS AND METHODS FOR TREATING INFLUENZA | NIEDRAUER MARY LYNN (US) | 2025-04-24 | — | — | WO | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| US-10072043-B2 | Inhibitors of protein tyrosine phosphatases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2018-09-11 | — | — | US | claimed |
| US-20160176922-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | Indiana University Research and Technology Corpora tion (US) | 2016-06-23 | — | — | US | claimed |
| US-9217012-B2 | Inhibitors of protein tyrosine phosphatases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2015-12-22 | — | — | US | claimed |
| US-20120088720-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATI (US) | 2012-04-12 | — | — | US | claimed |
| WO-2010118241-A2 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) | 2010-10-14 | — | — | WO | claimed |
| WO-1998008875-A1 | NOVEL COMBINATION PREPARATIONS AND THEIR USE IN IMMUNODIAGNOSIS AND IMMUNOTHERAPY | VIVA DIAGNOSTIKA DIAGNOSTISCHE PRODUKTE GMBH (DE) | 1998-03-05 | — | — | WO | claimed |
| EP-0815872-A2 | Compounds for targeting | IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 1998-01-07 | — | — | EP | claimed |
| EP-0679094-A1 | COMPOUNDS FOR TARGETING | IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 1995-11-02 | — | — | EP | claimed |
| WO-1994015644-A1 | COMPOUNDS FOR TARGETING | IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 1994-07-21 | — | — | WO | claimed |
| JP-6277046-A | — | — | None | — | — | JP | disclosed |
| WO-2026106497-A2 | FUNCTIONALIZED CIRCULAR RNA AND METHODS AND INTERMEDIATES FOR THEIR PRODUCTION | SIEĆ BADAWCZA ŁUKASIEWICZ – PORT POLSKI OSRODEK ROZWOJU TECHNOLOGII (PL) | 2026-05-21 | — | — | WO | disclosed |
| CN-122055148-A | Conjugates, compositions and methods for treating influenza | 珀杜研究基金会 | 2026-05-15 | — | — | CN | disclosed |
| US-4415751-A | Process for preparing phenylalkanoic acids | ELI LILLY AND COMPANY (US) | 1983-11-15 | — | — | US | disclosed |
| EP-0089805-A2 | Process for preparing phenylalkanoic acids | ELI LILLY AND COMPANY (US) | 1983-09-28 | — | — | EP | disclosed |
| EP-0081321-A1 | 2-Aminophenol derivatives | ONO PHARMACEUTICAL CO., LTD. (JP) | 1983-06-15 | — | — | EP | disclosed |
| EP-0062440-A1 | Process for preparing phenylalkanoic acids and derivatives of benzoxazole therefrom | ELI LILLY AND COMPANY (US) | 1982-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10072043-B2 | Inhibitors of protein tyrosine phosphatases | PTPRCAP, PTPRF, PTPRS | MAPT 2153/4885TSHR 1605/4885GAA 360/4885 |
| US-20160176922-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | PTPRCAP, PTPRF, PTPRS | MAPT 2153/4885TSHR 1605/4885GAA 360/4885 |
| US-20120088720-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | PTPRCAP, PTPRF, PTPRS | MAPT 2153/4885TSHR 1605/4885GAA 360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.